Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v2.4.0.6
Consolidated Statements of Operations and Comprehensive Loss (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Revenue $ 60,000 $ 6,135 $ 71,931 $ 342,097
Operating expenses:        
Research and development 2,476,113 1,866,252 6,419,827 4,301,851
Selling, general and administrative 2,970,837 1,727,145 5,545,467 4,628,853
Total operating expenses 5,446,950 3,593,397 11,965,294 8,930,704
Loss from operations (5,386,950) (3,587,262) (11,893,363) (8,588,607)
Other income (expense):        
Interest income 8,170 2,984 17,903 6,503
Interest expense (321,405) (1,058) (615,076) (2,665)
Change in derivative liabilities (92,805) (10,352) (276,889) (964,141)
Other (41,832) (386) (56,469) (1,097)
Total other expense, net (447,872) (8,812) (930,531) (961,400)
Loss before income taxes (5,834,822) (3,596,074) (12,823,894) (9,550,007)
Benefit from income tax   478,444   999,257
Loss from continuing operations (5,834,822) (3,117,630) (12,823,894) (8,550,750)
Discontinued operations - Income from operations, net of tax effect   928,740   1,939,731
Net loss and comprehensive loss (5,834,822) (2,188,890) (12,823,894) (6,611,019)
Preferred stock dividends (25,000) (25,000) (50,000) (50,000)
Net loss and comprehensive loss attributable to common stockholders $ (5,859,822) $ (2,213,890) $ (12,873,894) $ (6,661,019)
Loss per common share (basic and diluted):        
Continuing operations $ (0.06) $ (0.03) $ (0.14) $ (0.10)
Discontinued operations   $ 0.01   $ 0.02
Attributable to common stockholders $ (0.06) $ (0.02) $ (0.14) $ (0.08)
Weighted average shares outstanding:        
Basic and diluted 94,664,659 89,660,089 94,368,690 87,549,776